Oncology

Flint, Mich.-based McLaren Proton Therapy Center is set to become the first in the world to offer patients proton therapy with Leo Cancer Care's upright treatment technology, it said in an email to Becker's on July 5.

Cleveland Clinic performed the first-in-the-world full multi-organ transplant in September to treat a patient with pseudomyxoma peritonei, a rare form of appendix cancer. 

Here are five recent cancer center donations Becker's has covered since April 20: 

A generation ago we spoke of cancer in hushed tones. We whispered about the suspected "Big C," diagnoses were kept secret, and that was that. 

Boston-based Dana-Farber Cancer Institute and Brigham and Women's Hospital were designated as a Pheo Para Clinical Center June 28 for patients with rare neuroendocrine tumors.

St. Louis-based Washington University School of Medicine received a $5.3 million grant June 28 from the National Cancer Institute of the National Institutes of Health for lung cancer recurrence research efforts. 

Here are four moves from leading cancer centers across the nation that Becker's has covered since June 8: 

Alex Adjei MD, PhD, will serve as the new chair of Cleveland Clinic's Taussig Cancer Institute starting in July, the system said June 23.

Nashville, Tenn.-based HCA Healthcare inked a deal with McKesson June 23 to enter a joint venture combining the two institutions' cancer research efforts.

The University of Texas MD Anderson Cancer Center, Invectys and the Cell Therapy Manufacturing Center entered a strategic collaboration last week to develop a "reliable, compliant and scalable" process for human leukocyte antigen CAR-T cell therapy for solid tumors.